Methicillin-Resistant Staphylococcus aureus Bloodstream Infections in Hospitalized Patients in Peru.
Humans
Methicillin-Resistant Staphylococcus aureus
/ genetics
Staphylococcus aureus
/ genetics
Peru
/ epidemiology
Staphylococcal Infections
/ epidemiology
Community-Acquired Infections
/ epidemiology
Exotoxins
/ genetics
Leukocidins
/ genetics
Sepsis
Microbial Sensitivity Tests
Anti-Bacterial Agents
/ pharmacology
Journal
The American journal of tropical medicine and hygiene
ISSN: 1476-1645
Titre abrégé: Am J Trop Med Hyg
Pays: United States
ID NLM: 0370507
Informations de publication
Date de publication:
01 11 2023
01 11 2023
Historique:
received:
23
01
2023
accepted:
16
07
2023
pmc-release:
01
11
2024
medline:
3
11
2023
pubmed:
19
9
2023
entrez:
18
9
2023
Statut:
epublish
Résumé
There is a knowledge gap in the epidemiology of methicillin-resistant Staphylococcus aureus (MRSA) causing bloodstream infections (BSIs) in Peru. Through a surveillance study in 13 hospitals of 10 Peruvian regions (2017-2019), we assessed the proportion of MRSA among S. aureus BSIs as well as the molecular typing of the isolates. A total of 166 S. aureus isolates were collected, and 36.1% of them were MRSA. Of note, MRSA isolates with phenotypic and genetic characteristics of the hospital-associated Chilean-Cordobes clone (multidrug-resistant SCCmec I, non-Panton-Valentine leukocidin [PVL] producers) were most commonly found (70%), five isolates with genetic characteristics of community-associated MRSA (CA-MRSA)-SCCmec IV, PVL-producer-(8.3%) were seen in three separate regions. These results demonstrate that hospital-associated MRSA is the most frequent MRSA found in patients with BSIs in Peru. They also show the emergence of S. aureus with genetic characteristics of CA-MRSA. Further studies are needed to evaluate the extension of CA-MRSA dissemination in Peru.
Identifiants
pubmed: 37722664
doi: 10.4269/ajtmh.23-0054
pii: tpmd230054
pmc: PMC10622478
doi:
Substances chimiques
Exotoxins
0
Leukocidins
0
Anti-Bacterial Agents
0
Types de publication
Journal Article
Research Support, N.I.H., Extramural
Research Support, Non-U.S. Gov't
Langues
eng
Sous-ensembles de citation
IM
Pagination
1118-1121Subventions
Organisme : FIC NIH HHS
ID : D43 TW009343
Pays : United States
Références
Clin Infect Dis. 2003 Jan 1;36(1):53-9
pubmed: 12491202
Int J Infect Dis. 2020 Jul;96:601-606
pubmed: 32505877
Clin Infect Dis. 2009 Dec 15;49(12):1861-7
pubmed: 19911971
Clin Infect Dis. 2019 Nov 27;69(12):2112-2118
pubmed: 30753447
Korean J Intern Med. 2019 Nov;34(6):1347-1362
pubmed: 29347812
Clin Infect Dis. 2008 Mar 15;46(6):799-806
pubmed: 18266610
Curr Protoc Microbiol. 2011 Feb;Chapter 9:Unit 9A.2
pubmed: 21400677
J Antimicrob Chemother. 2018 Jan 01;73(1):212-222
pubmed: 29045648
J Clin Microbiol. 2005 Oct;43(10):5026-33
pubmed: 16207957
J Infect. 2012 Nov;65(5):406-11
pubmed: 22750236
Clin Infect Dis. 2020 Apr 10;70(8):1666-1674
pubmed: 31185081
Lancet Infect Dis. 2014 Oct;14(10):967-75
pubmed: 25185461
Antimicrob Agents Chemother. 2017 Sep 22;61(10):
pubmed: 28760895
Clin Infect Dis. 1999 Nov;29(5):1128-32
pubmed: 10524952
Am J Trop Med Hyg. 2021 Dec 06;106(2):432-440
pubmed: 34872054